相关实验视频

Updated: Jan 11, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

增殖性玻璃红蛋白病变中缺氧诱导的区域异质性:对向疗法的影响

Wenjie Yin¹, Miao Xu², Yan Gao¹

¹Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, PR China.

The Journal of pathology

|November 11, 2025

概括

增殖性视网膜病变 (PVR) 涉及基于视网膜位置的不同细胞类型. 缺氧驱动PVR,但有针对性的疗法,包括高氧症,显示出治疗这种视力威胁的条件的希望.

科学领域:

眼科医生眼科眼科
细胞生物学细胞生物学
病理学病理学病理学

背景情况:

增殖性玻璃红蛋白病变 (PVR) 是眼睛受伤后导致失明的主要原因.
目前的研究重点是视网膜色素上皮质 (RPE) 中介细胞过渡作为主要原因.
由于对PVR的发病因子的理解尚不完全,因此需要新的治疗点.

研究的目的:

根据视网膜位置调查PVR膜的细胞病理特征.
确定在不同视网膜区域驱动PVR的独特分子通路.
评估针对低氧诱导PVR的新型治疗策略.

主要方法:

单细胞测序和手术切除PVR膜的免疫光染色.
对细胞组成 (巨细胞,RPE细胞) 和分子标记物 (PMEL) 的分析.
用向疗法和高氧治疗的视网膜损伤的体内小鼠模型.

主要成果:

视网膜PVR膜富含巨细胞,而视网膜PVR膜含有PMEL+ RPE衍生细胞.
这两种PVR类型都与视网膜缺氧有关,但利用不同的下游途径 (HIF1α-糖解与活性氧物种).
针对性抑制糖解或活性氧物种减少了特定的PVR类型;高氧化消除了小鼠模型中的PVR.

结论:

PVR表现出缺氧诱导的区域异质性,具有明显的细胞和分子形状.
治疗策略应在解剖学上针对特定的PVR亚型.
过氧症为PVR提供了一个潜在的泛区域治疗方法.

关键词:

细胞异质性的细胞异质性细胞代谢的细胞代谢缺氧缺氧是指缺氧的情况.增殖性玻璃乙烯基红蛋白病变单细胞转录基因组测序

更多相关视频

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies

Published on: March 12, 2022

相关概念视频

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...